All cancers - Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)

Phase II, multi-center, open-label study of patients with advanced solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3.

Learn more at NCT02576431

Adult Brain Cancer, Adult Breast Cancer, Cancer, Adult Gastrointestinal Cancer, Adult Gynecologic Malignancies, Adult Hematologic Malignancies, Adult Lung Cancer, Adult Multiple/Other Cancers